文献速递关节外科创伤骨科

髋关节复发性假体周围感染再次行二期翻修置换术:令人警醒的结果

Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results.
PubMed 文献 · J Arthroplasty · 2025-02-14

本研究回顾性分析52例因复发性假体周围感染行再次二期翻修全髋关节置换术的患者,平均随访6年,7年无再翻修感染生存率为85%,但无任何再翻修生存率仅57%,主要再翻修指征为脱位(45%)和假体周围感染(35%)。McPherson宿主C级是感染再翻修的显著危险因素(HR 5,P=0.04)。

要点

  • 再次二期翻修术后7年无感染再翻修生存率85%,无任何再翻修生存率57%。
  • 再翻修主要原因为脱位(45%)和假体周围感染(35%)。
  • McPherson宿主C级患者感染再翻修风险为5倍(HR 5,P=0.04)。

核心结论

  • 再次二期翻修全髋关节置换术7年无感染再翻修生存率为85%,但无任何再翻修生存率仅57%,多数因脱位而再翻修。
  • McPherson宿主C级患者 reinfection 风险增加5倍(HR 5,P=0.04)。

研究设计与样本

  • 回顾性研究,纳入2000年至2021年间在单一高容量学术医学中心完成的52例再次二期翻修全髋关节置换术。
  • 患者平均年龄61岁,39%为女性,平均体重指数33;再次二期翻修时90%使用高剂量抗生素间隔物(28例关节型,19例非关节型),10%在两次手术间期行切除关节成形术。
  • 再次第一期至再植入的平均时间为33周,末次随访时54%患者接受慢性抗生素治疗,平均随访6年。

主要发现

  • 7年无再翻修感染生存率、无任何再翻修生存率、无任何再手术生存率分别为85%、57%、50%。
  • 再翻修的主要指征为脱位(45%)和假体周围感染(35%)。
  • McPherson宿主C级是感染再翻修的显著危险因素(HR 5,P=0.04)。
  • 再植入时手术时间延长是全因再手术(HR 1.06,P<0.01)和感染再手术(HR 1.07,P<0.01)的危险因素。
  • 末次随访时98%患者保留翻修全髋关节假体(1例髋关节离断)。

局限性

  • 证据等级为IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A two-stage exchange arthroplasty is the standard management method of chronic periprosthetic joint infections (PJIs) of the hip in North America. However, a subset of patients become reinfected and may require a repeat two-stage exchange arthroplasty. The purpose of the present study was to assess revisions, reoperations, and risk factors for failure associated with repeat two-stage exchange arthroplasties for recurrent PJIs after total hip arthroplasty (THA). METHODS: We identified 52 repeat two-stage exchange THAs completed from 2000 to 2021 at a single, high-volume academic medical center. The mean age was 61 years, 39% were women, and the mean body mass index was 33. At the time of the repeat two-stage exchange, high-dose antibiotic spacers were used in 90% of patients (28 articulating, 19 nonarticulating), and 10% had a resection arthroplasty in the interim between stages. The mean time from repeat first stage to reimplantation was 33 weeks. At the final follow-up, 54% of patients were on chronic antibiotic therapy. The mean follow-up was 6 years. RESULTS: The 7-year survivorships free of re-revision for reinfection, any re-revision, and any reoperation were 85, 57, and 50%, respectively. The leading indications for re-revision were dislocation (45%) and PJI (35%). McPherson host grade C was a significant risk factor for re-revision for infection (HR [hazard ratio] 5, P = 0.04). Additionally, increased operative time at reimplantation was a risk for any reoperation (HR 1.06, P < 0.01) and reoperation for infection (HR 1.07, P < 0.01). At the final follow-up, 98% of patients had a revision THA in situ (one hip disarticulation). CONCLUSIONS: Repeat two-stage exchange arthroplasty of the hip had a 7-year survivorship free of re-revision for infection that was 85%, but only 57% were free of any re-revision (most due to revision for dislocation). McPherson C hosts had a 5-fold increased risk of reinfection. LEVEL OF EVIDENCE: Level IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Owen AR, Dilger OB, Bedard NA, et al. Repeat Two-Stage Exchange Arthroplasty for Recurrent Periprosthetic Joint Infection of the Hip: Sobering Results. J Arthroplasty. 2025. PMID: 39956489. doi:10.1016/j.arth.2025.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。